Alina Baum
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- Immunology top 5%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- interferon and immune responses 8
- Immune Response and Inflammation 5
-
- SARS-CoV-2 and COVID-19 Research 3
- Viral Infections and Outbreaks Research 2
- Viral Infections and Vectors 2
- Co-authors
- Adolfo Garcı́a-Sastre (8 shared papers)Ravi Sachidanandam (1 shared paper)Christos A. Kyratsous (6 shared papers)Richard Copin (2 shared papers)Gurinder S. Atwal (2 shared papers)Neil Stahl (1 shared paper)Kristen E. Pascal (2 shared papers)Andrew Murphy (1 shared paper)
- Journals
- Virulence (1 paper)PLoS Pathogens (1 paper)Amino Acids (1 paper)Integrative Biology (1 paper)EBioMedicine (1 paper)
- Partner nations
- United StatesSouth KoreaCzechia
In The Last Decade
Alina Baum
13 papers receiving 1.5k citations
Alina Baum's Hit Papers
Peers
Comparison fields: 5 of 75
- Infectious Diseases 887
- Immunology 617
- Animal Science and Zoology 177
- Epidemiology 323
- Molecular Biology 464
Countries citing papers authored by Alina Baum
This map shows the geographic impact of Alina Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Baum more than expected).
Fields of papers citing papers by Alina Baum
This network shows the impact of papers produced by Alina Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Baum. The network helps show where Alina Baum may publish in the future.
Co-authors
The 25 scholars most cited alongside Alina Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies Hit paper breakdown → | 2020 | 719 |
| 2 | 2010 | 339 | |
| 3 | 2009 | 108 | |
| 4 | 2014 | 107 | |
| 5 | 2013 | 101 | |
| 6 | 2011 | 51 | |
| 7 | 2017 | 22 | |
| 8 | 2012 | 16 | |
| 9 | 2017 | 15 | |
| 10 | 2021 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 1 | |
| 14 | 2024 | 0 |
About Alina Baum
Alina Baum is a scholar working on Immunology, Infectious Diseases, Molecular Biology, Oncology and Epidemiology, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), Immune Response and Inflammation (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Animal Virus Infections Studies (2 papers), Viral Infections and Outbreaks Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Viral Infections and Vectors (2 papers). The work is most often cited by research in Infectious Diseases (887 citations), Immunology (617 citations), Animal Science and Zoology (177 citations), Epidemiology (323 citations) and Molecular Biology (464 citations). Alina Baum has collaborated with scholars based in United States, South Korea and Czechia. Frequent co-authors include Adolfo Garcı́a-Sastre, Ravi Sachidanandam, Christos A. Kyratsous, Richard Copin, Gurinder S. Atwal, Neil Stahl, Kristen E. Pascal, Andrew Murphy, Elzbieta Wloga and Min Ni. Their work appears in journals such as Virulence, PLoS Pathogens, Amino Acids, Integrative Biology and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.